92 related articles for article (PubMed ID: 15650257)
1. Inhibition of cell migration via G protein-coupled receptors to opioid peptides and angiotensin.
Entschladen F; Bastian P; Niggemann B; Zaenker KS; Lang K
Ann N Y Acad Sci; 2004 Dec; 1028():320-8. PubMed ID: 15650257
[TBL] [Abstract][Full Text] [Related]
2. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
3. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
4. Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors.
Morou E; Georgoussi Z
J Pharmacol Exp Ther; 2005 Dec; 315(3):1368-79. PubMed ID: 16160084
[TBL] [Abstract][Full Text] [Related]
5. The involvement of protein kinases in signalling of opioid agonist FK 33-824 in porcine granulosa cells.
Kaminski T
Anim Reprod Sci; 2006 Jan; 91(1-2):107-22. PubMed ID: 16310101
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors.
Börner C; Kraus J; Bedini A; Schraven B; Höllt V
Mol Pharmacol; 2008 Aug; 74(2):496-504. PubMed ID: 18463202
[TBL] [Abstract][Full Text] [Related]
7. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin engagement provides a dominant stop signal for the migration of MDA-MB-468 breast carcinoma cells.
Potthoff S; Entschladen F; Niggemann B; Zaenker KS; Lang K
Breast Cancer Res Treat; 2007 Nov; 105(3):287-95. PubMed ID: 17171299
[TBL] [Abstract][Full Text] [Related]
10. Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules.
Gintzler AR; Chakrabarti S
Life Sci; 2006 Jul; 79(8):717-22. PubMed ID: 16581089
[TBL] [Abstract][Full Text] [Related]
11. Effects of met-enkephalin on cell proliferation in different models of adrenocortical-cell growth.
Malendowicz LK; Rebuffat P; Tortorella C; Nussdorfer GG; Ziolkowska A; Hochol A
Int J Mol Med; 2005 May; 15(5):841-5. PubMed ID: 15806307
[TBL] [Abstract][Full Text] [Related]
12. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
[TBL] [Abstract][Full Text] [Related]
13. Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism.
Witkowski G; Szulczyk P
Brain Res; 2006 Jun; 1094(1):92-106. PubMed ID: 16733049
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
Li Y; Hashim S; Anand-Srivastava MB
Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitters are regulators for the migration of tumor cells and leukocytes.
Entschladen F; Lang K; Drell TL; Joseph J; Zaenker KS
Cancer Immunol Immunother; 2002 Nov; 51(9):467-82. PubMed ID: 12357318
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of opioid-mediated inhibition of human T cell receptor signaling.
Börner C; Warnick B; Smida M; Hartig R; Lindquist JA; Schraven B; Höllt V; Kraus J
J Immunol; 2009 Jul; 183(2):882-9. PubMed ID: 19561113
[TBL] [Abstract][Full Text] [Related]
18. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
[TBL] [Abstract][Full Text] [Related]
19. Multiple opioid receptors on immune cells modulate intracellular signaling.
Sharp BM
Brain Behav Immun; 2006 Jan; 20(1):9-14. PubMed ID: 16364815
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
